
Renal Toxicity Uncommon in Patients with Breast Cancer & Bone Mets Treated with Ibandronate
Author(s) -
Ed Susman
Publication year - 2005
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000287788.87212.92
Subject(s) - medicine , nephrotoxicity , breast cancer , renal function , placebo , adverse effect , zoledronic acid , kidney disease , bisphosphonate , creatinine , urology , cancer , surgery , toxicity , osteoporosis , pathology , alternative medicine